{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:53:00Z","timestamp":1753739580986,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":50,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642289507"},{"type":"electronic","value":"9783642289514"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-28951-4_3","type":"book-chapter","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T09:30:23Z","timestamp":1350898223000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Surveillance Programmes and Antibiotic Resistance: Worldwide and Regional Monitoring of Antibiotic Resistance Trends"],"prefix":"10.1007","author":[{"given":"Stephen","family":"Hawser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,7]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/S1413-86702008000200009","volume":"12","author":"S Andrade","year":"2008","unstructured":"Andrade S, Sader HS, Barth A (2008) Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003\u20132008). Braz J Infect Dis 12:3\u20139","journal-title":"Braz J Infect Dis"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02724275","volume":"71","author":"JY Ang","year":"2004","unstructured":"Ang JY, Ezike E, Asmar BL (2004) Antibacterial resistance. Indian J Pediatr 71:229\u2013239","journal-title":"Indian J Pediatr"},{"key":"3_CR4","first-page":"1","volume":"33","author":"Australian Government, Department of Health and Ageing","year":"2009","unstructured":"Australian Government, Department of Health and Ageing (2009) Quarterly report. Comm Dis Intell 33:1\u201386","journal-title":"Comm Dis Intell"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1054\/drup.2000.0167","volume":"3","author":"TM Barbosa","year":"2000","unstructured":"Barbosa TM, Levy SB (2000) The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 3:303\u2013311","journal-title":"Drug Resist Updat"},{"key":"3_CR6","first-page":"59","volume":"50","author":"DJ Biedenbach","year":"2004","unstructured":"Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997\u20132002) Diagn Micro. Infect Dis 50:59\u201369","journal-title":"Infect Dis"},{"key":"3_CR7","doi-asserted-by":"crossref","unstructured":"Castanheira M, Deshpande LM, Bell JM et al (2010) Early dissemination of NDM-1 and OXA-181-producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2006\u20132007). Antimicrob Agents Chemother. doi: 10.1128\/AAC.01497-10","DOI":"10.1128\/AAC.01497-10"},{"key":"3_CR8","unstructured":"Centers for Disease Control and Prevention (2009a) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2009"},{"key":"3_CR9","unstructured":"Centers for Disease Control and Prevention (2009b) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningiditis, 2009"},{"key":"3_CR10","unstructured":"Centers for Disease Control and Prevention (2009c) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2009"},{"key":"3_CR11","unstructured":"Centers for Disease Control and Prevention (2009d) Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008"},{"key":"3_CR12","volume-title":"National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2008","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention (2010) National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2008. US Department of Health and Human Services, CDC, Atlanta, Georgia"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0924-8579(02)00394-1","volume":"21","author":"M Cizman","year":"2003","unstructured":"Cizman M (2003) The use and resistance to antibiotics in the community. Int J Antimicrob Agents 21:297\u2013307","journal-title":"Int J Antimicrob Agents"},{"key":"3_CR14","unstructured":"DANMAP (2009) DANMAP 2009-Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. ISSN 1600\u20132032"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2009.12.009","volume":"67","author":"A Darabi","year":"2010","unstructured":"Darabi A, Hocquet D, Dowzicky MJ (2010) Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial. Diagn Microbiol Infect Dis 67:78\u201386","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0140-6736(00)90015-1","volume":"355","author":"P De Man","year":"2000","unstructured":"De Man P, Verhoeven BA, Verbrugh HA et al (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973\u2013978","journal-title":"Lancet"},{"key":"3_CR17","volume-title":"Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","author":"European Centre for Disease Prevention and Control","year":"2010","unstructured":"European Centre for Disease Prevention and Control (2010) Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm"},{"issue":"Suppl 2","key":"3_CR18","doi-asserted-by":"publisher","first-page":"ii87","DOI":"10.1093\/jac\/dkn355","volume":"62","author":"DJ Farrell","year":"2008","unstructured":"Farrell DJ, Felmingham D, Shackcloth J et al (2008) Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and bacteremias in the UK and Ireland, 1999 to 2007. J Antimicrob Chemother 62(Suppl 2):ii87\u2013ii95","journal-title":"J Antimicrob Chemother"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jac\/45.2.191","volume":"45","author":"D Felmingham","year":"2000","unstructured":"Felmingham D, Grunenburg RN, The Alexander Project Group (2000) The Alexander Project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45:191\u2013203","journal-title":"J Antimicrob Chemother"},{"key":"3_CR20","first-page":"160","volume":"54","author":"N Frimodt-Moller","year":"2007","unstructured":"Frimodt-Moller N, Hammerum AM, Hessler JHR et al (2007) Global development of resistance. Dan Med Bull 54:160\u2013162","journal-title":"Dan Med Bull"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1590\/S1413-86702009000200004","volume":"13","author":"AC Gales","year":"2009","unstructured":"Gales AC, Sader HS, Ribeiro J et al (2009) Antimicrobial susceptibility of Gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY program (2005\u20132008). Braz J Infect Dis 13:90\u201398","journal-title":"Braz J Infect Dis"},{"issue":"Suppl 3","key":"3_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1469-0691.2006.01397.x","volume":"12","author":"C Garcia-Rey","year":"2006","unstructured":"Garcia-Rey C, Martin-Herrero JE, Baquero F (2006) Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clin Micro Infect 12(Suppl 3):55\u201366","journal-title":"Clin Micro Infect"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","volume":"365","author":"H Goossens","year":"2005","unstructured":"Goossens H, Ferech M, Vander Stichele R et al (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579\u2013587","journal-title":"Lancet"},{"key":"3_CR24","unstructured":"Government of Canada (2010) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2007. Public Health Agency of Canada"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jama.279.5.365","volume":"279","author":"D Guillemot","year":"1998","unstructured":"Guillemot D, Carbon C, Balkau B et al (1998) Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumonaie. JAMA 279:365\u2013370","journal-title":"JAMA"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10096-010-0962-7","volume":"29","author":"SP Hawser","year":"2010","unstructured":"Hawser SP (2010) Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe. Eur J Clin Microbiol Infect Dis 29:1011\u20131013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1128\/AAC.00426-09","volume":"53","author":"SP Hawser","year":"2009","unstructured":"Hawser SP, Bouchillon SK, Hoban DJ et al (2009) Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53:3280\u20133284","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/sur.2009.057","volume":"11","author":"SP Hawser","year":"2010","unstructured":"Hawser SP, Bouchillon SK, Hoban DJ et al (2010a) Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002 to 2007 from the SMART study. Surg Infect 11:371\u2013378","journal-title":"Surg Infect"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1128\/AAC.00265-10","volume":"54","author":"SP Hawser","year":"2010","unstructured":"Hawser SP, Bouchillon SK, Hoban DJ et al (2010b) Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe \u2013 Results of the 2008 SMART Study. Antimicrob Agents Chemother 54:3043\u20133046","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijantimicag.2010.04.009","volume":"36","author":"SP Hawser","year":"2010","unstructured":"Hawser SP, Hackel M, Person MB et al (2010c) In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii. Int J Antimicrob Agents 36:289\u2013290","journal-title":"Int J Antimicrob Agents"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/jac\/dkq016","volume":"65","author":"SP Hawser","year":"2010","unstructured":"Hawser SP, Hackel M, Hoban DJ (2010d) Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility. J Antimicrob Chemother 65:803\u2013804","journal-title":"J Antimicrob Chemother"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2009.06.009","volume":"66","author":"DJ Hoban","year":"2010","unstructured":"Hoban DJ, Bouchillon SK, Hawser SP et al (2010) Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diag Microbiol Infect Dis 66:78\u201386","journal-title":"Diag Microbiol Infect Dis"},{"issue":"Suppl 2","key":"3_CR33","doi-asserted-by":"publisher","first-page":"ii65","DOI":"10.1093\/jac\/dkn353","volume":"62","author":"R Hope","year":"2008","unstructured":"Hope R, Livermore DM, Brick G et al (2008) Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001\u20132006. J Antimicrob Chemother 62(Suppl 2):ii65\u2013ii74","journal-title":"J Antimicrob Chemother"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijantimicag.2010.07.002","volume":"36","author":"PR Hsueh","year":"2010","unstructured":"Hsueh PR, Badal RE, Hawser SP et al (2010) Asia\u2013Pacific SMART Group. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART. Int J Antimicrob Agents 36:408\u2013414","journal-title":"Int J Antimicrob Agents"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0732-8893(96)00099-5","volume":"25","author":"RN Jones","year":"1996","unstructured":"Jones RN (1996) The emergent needs for basic research, education and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diag Micro Infect Dis 25:153\u2013161","journal-title":"Diag Micro Infect Dis"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0732-8893(99)00110-8","volume":"35","author":"RN Jones","year":"1999","unstructured":"Jones RN (1999) Beta-lactam resistance surveillance in the Asia-Western Pacific region. Diag Micro Infect Dis 35:333\u2013338","journal-title":"Diag Micro Infect Dis"},{"key":"3_CR37","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-6042-9","volume-title":"The antibiotic paradox","author":"SB Levy","year":"1992","unstructured":"Levy SB (1992) The antibiotic paradox. Plenum, New York"},{"issue":"Suppl 2","key":"3_CR38","doi-asserted-by":"publisher","first-page":"ii55","DOI":"10.1093\/jac\/dkn352","volume":"62","author":"DM Livermore","year":"2008","unstructured":"Livermore DM, Hope R, Brick G et al (2008a) Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001\u20132006. J Antimicrob Chemother 62(Suppl 2):ii55\u2013ii63","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"3_CR39","doi-asserted-by":"publisher","first-page":"ii41","DOI":"10.1093\/jac\/dkn351","volume":"62","author":"DM Livermore","year":"2008","unstructured":"Livermore DM, Hope R, Brick G et al (2008b) Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001\u20132006. J Antimicrob Chemother 62(Suppl 2):ii41\u2013ii54","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"3_CR40","doi-asserted-by":"publisher","first-page":"ii97","DOI":"10.1093\/jac\/dkn356","volume":"62","author":"I Morrisey","year":"2008","unstructured":"Morrissey I, Maher K, Williams L et al (2008) Non-susceptibility trends amonh Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999\u20132007. J Antimicrob Chemother 62(suppl 2):ii97\u2013ii103","journal-title":"J Antimicrob Chemother"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002727-200407000-00005","volume":"27","author":"PM Myrianthefs","year":"2004","unstructured":"Myrianthefs PM, Kalafati M, Samara I et al (2004) Nosocomial pneumonia. Crit Care Nurs Q 27:241\u2013257","journal-title":"Crit Care Nurs Q"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/00365540903244543","volume":"42","author":"E Nagy","year":"2010","unstructured":"Nagy E, Dowzicky MJ (2010) In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Scand J Infect Dis 42:33\u201338","journal-title":"Scand J Infect Dis"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1590\/S1413-86702004000100004","volume":"8","author":"HS Sader","year":"2004","unstructured":"Sader HS, Jones RN, Gales AC et al (2004) SENTRY antimicrobial surveillance program report: Latin America and Brazilian results for 1997 through 2001. Braz J Infect Dis 8:25\u201379","journal-title":"Braz J Infect Dis"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1086\/520195","volume":"29","author":"DF Sahm","year":"1999","unstructured":"Sahm DF, Marsilio MK, Piazza G (1999) Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 29:259\u2013263","journal-title":"Clin Infect Dis"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1000377","volume":"7","author":"AH Skalet","year":"2010","unstructured":"Skalet AH, Cevallos V, Ayele B et al (2010) Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: A cluster-randomized clinical trial. PLoS Med 7:1\u20139","journal-title":"PLoS Med"},{"key":"3_CR46","volume-title":"The path of least resistance","author":"Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance","year":"1998","unstructured":"Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance (1998) The path of least resistance. Department of Health, London"},{"key":"3_CR47","unstructured":"SWEDRES (2009) A report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine. Swedish Strategic Programme against Antibiotic Resistance (STRAMA), Stockholm"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1590\/S0037-86822010000600005","volume":"43","author":"M Tresoldi das Neves","year":"2010","unstructured":"Tresoldi das Neves M, Pinto de Lorenzo ME, Almeida RAMB et al (2010) Antimicrobial use and incidence of multidrug-resistant Pseudomonas aeruginosa in a teaching hospital: an ecological approach. Rev Soc Brasil Med Trop 43:629\u2013632","journal-title":"Rev Soc Brasil Med Trop"},{"key":"3_CR49","volume-title":"Guidelines for antimicrobial resistance surveillance; WHO Regional Publications Eastern Mediterranean Series 15","author":"J Vandepitte","year":"1996","unstructured":"Vandepitte J, El-Nageh M, Tikhomirov E et al (1996) Guidelines for antimicrobial resistance surveillance; WHO Regional Publications Eastern Mediterranean Series 15. WHO Regional Office for the Eastern Mediterranean, Alexandria"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2010.04.002","volume":"68","author":"YF Wang","year":"2010","unstructured":"Wang YF, Dowzicky MJ (2010) In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagn Microbiol Infect Dis 68:73\u201379","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8603-2-6","volume":"2","author":"R Zhang","year":"2006","unstructured":"Zhang R, Eggleston K, Rotimi V et al (2006) Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2:6","journal-title":"Global Health"}],"container-title":["Handbook of Experimental Pharmacology","Antibiotic Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-28951-4_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T01:12:48Z","timestamp":1675213968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-28951-4_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642289507","9783642289514"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-28951-4_3","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"7 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}